Business Context and Reporting Period
Company: Oramed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 12, 2011
Event Date: May 11, 2011
This filing discloses a Regulation FD event wherein the company announced its selection to present at the 10th National Life Science & Technology Week ILSI-BIOMED Conference in Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements.
Material Changes
No material financial changes versus a prior comparable period are reported in this document.
Outlook, Commentary, and Risks
- Management Commentary: Nadav Kidron, President, CEO, and Director, is scheduled to present at the ILSI-BIOMED Conference.
- Event Details: The presentation will occur on Tuesday, May 24, 2011, at 12:50 p.m. (IDT) during the BioPharma Session at the David Intercontinental Hotel in Tel-Aviv, Israel.
- Risks and Contingencies: No specific risks or contingencies are detailed in this filing.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific details on the company's presentation.
- Confirm the date and location of the ILSI-BIOMED Conference presentation (May 24, 2011, Tel-Aviv).
- Review subsequent filings for any financial updates or results discussed during the conference.